menu
    • menu

    Company profile for ZyVersa Therapeutics, Inc

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs. Our focus is on patients with inflammatory or renal diseases who have high unmet medical needs. Our clinical pipeline includes phase 2a-ready VAR 200, a cholesterol efflux mediator for treatment of an orphan renal disease, focal segmental glomerulosclerosis (FSGS), and a novel inflammaso...
    ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs. Our focus is on patients with inflammatory or renal diseases who have high unmet medical needs. Our clinical pipeline includes phase 2a-ready VAR 200, a cholesterol efflux mediator for treatment of an orphan renal disease, focal segmental glomerulosclerosis (FSGS), and a novel inflammasome inhibitor with potential for multiple inflammatory diseases. Our accomplished leadership team has demonstrated success across all disciplines in the biopharmaceutical industry.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ZyVersa Therapeutics, IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2200 N. Commerce Parkway Suite 208 Weston, FL 3332
    Telephone
    Telephone
    754-231-1688
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.zyversa.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/zyversa.com
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zyversa Therapeutics Reports Third Quarter 2025 Financial Results
    Zyversa Therapeutics Reports Third Quarter 2025 Financial Results

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191443/0/en/ZyVersa-Therapeutics-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    ZyVersa' Data Shows Potential of Inhibitors to Improve T2D
    ZyVersa' Data Shows Potential of Inhibitors to Improve T2D

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147676/0/en/ZyVersa-Therapeutics-Highlights-Data-Reinforcing-the-Potential-of-Inflammasome-Inhibitors-to-Attenuate-Progression-of-Type-2-Diabetes-and-Improve-Associated-Long-term-Cardiovascula.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    ZyVersa Highlights Lipidomic Data in Alport Syndrome and DKD
    ZyVersa Highlights Lipidomic Data in Alport Syndrome and DKD

    03 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/03/3143489/0/en/ZyVersa-Therapeutics-Highlights-Lipidomic-Data-in-Alport-Syndrome-and-DKD-Reinforcing-the-Need-for-Drugs-to-Attenuate-Damaging-Renal-Lipid-Accumulation-to-Mitigate-Disease-Progress.html

    GLOBENEWSWIRE
    03 Sep 2025
    Share Share
    Zy Versa Therapeutics Spotlights Data on Kidney Lipotoxicity
    Zy Versa Therapeutics Spotlights Data on Kidney Lipotoxicity

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133385/0/en/ZyVersa-Therapeutics-Highlights-Data-Demonstrating-a-Critical-Need-for-Therapies-to-Address-Kidney-Lipotoxicity-to-Alleviate-Diabetic-Kidney-Disease-DKD-and-Its-Progression.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    ZyVersa Therapeutics Announces Q2 2025 Results and Key Milestones
    ZyVersa Therapeutics Announces Q2 2025 Results and Key Milestones

    13 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/13/3132643/0/en/ZyVersa-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Highlights-Key-Near-term-Value-building-Milestones.html

    GLOBENEWSWIRE
    13 Aug 2025
    Share Share
    ZyVersa CEO's Mid-Year Letter Highlights Corporate & R&D Develop
    ZyVersa CEO's Mid-Year Letter Highlights Corporate & R&D Develop

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118650/0/en/ZyVersa-Therapeutics-CEO-Issues-Mid-year-Shareholder-Letter-Highlighting-Recent-Corporate-Developments-and-R-D-Progress.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search